• 00Days to go

Information for delegates

All travellers (except Australian and New Zealand citizens) must have a valid visa before arriving in Australia.

To apply for a visa to attend ORL HNS 2023:

1. Register to attend the congress, registrations will open in 2022.

When you register and pay to attend the congress, you will receive an acknowledgement letter that you can use with your visa application.

2. Apply for a visa at the Department of Home Affairs.

Use the Visa Finder to determine the right visa for you and follow the steps to apply for your visa.

At a minimum, you should apply for your visa 6 weeks before your arrival date in Australia.

For useful tips for safe travel click here.

Visa Options

The Congress organisers are not visa experts. Please reach out to the Australian Government to confirm the application process for your country. We can assist in providing you with a visa letter once you have finalised and paid for your registration.

Participants, attendees and speakers that will not be working, performing or otherwise be paid to contribute at the event may be eligible to apply for the following visa options:

  • Visitor (subclass 600)(Business stream) visa.  For more information click here
  • Electronic Travel Authority – ETA (subclass 601).  For eligible passport holders and more information click here. 
  • Visitor (subclass 651)(Business Stream) visa.  For eligible passport holders and more information click here.

A speaker, presenter, exhibitor, or other contributor invited to participate in an event by an Australian organisation may be eligible to apply for a:

  • Temporary Activity (subclass 408)(Invited Participant) visa.  For more information click here

Prof Sarah Wise

Emory University School of Medicine

Sarah K. Wise, MD, MSCR is Professor of Otolaryngology-Head and Neck Surgery at Emory University in Atlanta, Georgia. She is the Emory Otolaryngology Residency Program Director, Rhinology Fellowship Director, and Director of Otolaryngic Allergy. Dr. Wise completed medical school at the University of Texas Health Science Center San Antonio, residency at Emory University and rhinology fellowship at the Medical University of South Carolina. Dr. Wise has served on the Board of Directors of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. She will become President of the American Rhinologic Society in September 2022, serving as the Society’s first female president. Her clinical interests include inflammatory rhinology, otolaryngic allergy, relationship of allergy and chronic rhinosinusitis, and cerebrospinal fluid leaks. Dr. Wise lectures nationally and internationally. Her most notable publication is the International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis, where she served as first author/primary editor.

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.